Source: Eur Respir Rev 2008; 17: 105-107



Rating:

Share or cite this content

Citations should be made in the following way:
King T. E. Jr, du Bois R. M.. Elucidating the causes and examining the latest clinical findings in pulmonary fibrosis. Eur Respir Rev 2008; 17: 105-107

Member's Comments

No comment yet.

Related content which might interest you: Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 48-56 Year: 2012 The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 Genetic testing in pulmonary hypertension: how should our clinical practice reflect recent advances? Source: Eur Respir J 2016; 47: 388-389 Year: 2016 Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Idiopathic pulmonary fibrosis: present understanding and future options Source: Eur Respir Rev 2011; 20: 132-133 Year: 2011 Endobronchial findings in pulmonary sarcoidosis and their association with clinical and functional parameters Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009 Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation Source: Eur Respir Rev 2015; 24: 436-444 Year: 2015 Frequencies and dynamics of peripheral immune cell subsets in idiopathic pulmonary fibrosis: Preliminary results and clinical implications Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 The relationship between radiologic findings and lung function impairment in chronic obstructive pulmonary disease Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012 Molecular endpoints for establishing target engagement by novel idiopathic pulmonary fibrosis therapies Source: Eur Respir J, 53 (3) 1900283; 10.1183/13993003.00283-2019 Year: 2019 Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities Source: Eur Respir Rev 2009; 18: 198-212 Year: 2009 Role of MUC1 in idiopathic pulmonary fibrosis: mechanistic insights Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 A recurring theme in pulmonary fibrosis genetics Source: Eur Respir J, 49 (5) 1700545; 10.1183/13993003.00545-2017 Year: 2017 Clinical features of combined pulmonary fibrosis and emphysema Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Recommendations for epidemiological studies on COPD Source: Eur Respir J 2011; 38: 1261-1277 Year: 2011